What is Capricor Therapeutics's interest expense?

Capricor Therapeutics (CAPR) reported interest expense of $761.43K in Q4 2025.

What does interest expense mean?

Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.

Capricor Therapeutics CAPR Interest Expense

Discontinued — last reported Q4 '25

Interest Expense at other companies

PTC TherapeuticsPTCT

-$49.03M-43.8%

VericelVCEL

$160K+4.6%

Dyne Therapeutics, Inc.DYN

$4.2M—

Viridian Therapeutics, Inc.VRDN

$3.46M+529%

LeMaitre VascularLMAT

$1.3M+0.8%

CytokineticsCYTK

$14.52M+63.7%

Segments

By segment

See full

Single Reportable$3.05M—

Other financials

Income statement

See full

Revenue--100%

Operating income-$36.8M-47.2%

Net income-$33.9M-39.2%

EPS (diluted)-$0.59-11.3%

Balance sheet

See full

Cash & equivalents$105.4M+266%

Total debt$14.8M+1,083%

Total equity$278.7M+118%

Total assets$326.3M+112%

Cash flow

See full

Operating cash flow-$29.3M-355%

CapEx$5.1M+472%

Free cash flow-$34.4M-369%

Valuation

See full

Market cap$1.71B+303%

Enterprise value$1.62B+308%

Profitability

See full

Operating margin-778.8%-1,038pp

Net margin-736.6%-981pp

FCF margin-563.9%-954pp

Returns & leverage

See full

Return on equity-56.4%-11.3pp

Debt / equity0.1×0.0×

Current ratio8.4×+1.9×

Where this comes from

Reported directly by Capricor Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Capricor Therapeutics’s 10-K, filed March 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about Capricor Therapeutics's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Capricor Therapeutics's interest expense?: Capricor Therapeutics (CAPR) reported interest expense of $761.43K in Q4 2025.
What does interest expense mean?: Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.